MDA‐MB‐231 is a breast cancer cell line generated from a patient with triple‐negative/basal‐like breast cancer, which is distinguished by the lack of ER, PR, and HER2 expression and has a poor prognosis. Here, ERBB2 is linked to breast carcinoma.